Metabolic Complications of Obesity

Obesity: Science to Practice

Volumn , Issue , 2009, Pages 237-270

  Ma, Ronald ^a   Chan, Juliana ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Ectopic triglyceride deposition; Endoplasmic reticulum stress (ER stress); Free fatty acids (FFA) valuable energy substrate; Insulin resistance describes reduced sensitivity of insulin's target tissues to the hormone's actions; Insulin resistance initially suggested as the central defect, is hard to measure in clinical practice and does not relate consistently to hypertension or other features of the syndrome; Lipid disorders regarded as components of a broader 'metabolic syndrome'; Metabolic complications of obesity; Renal dysfunction; Subcutaneous fat releases more leptin

Indexed keywords

EID: 66249093089     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470712221.ch10     Document Type: Chapter

References (260)

1. AdieLs, M., Olofsson, S.O., Taskinen, M.R. and Boren, J. (2006) Diabetic dyslipidaemia. Current Opinion in Lipidoíogy, 17, 238-46.
2. Aggarwal, B.B. (2000) Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB. Annals of the Rheumatic Diseases, 59 (Suppl 1), 16-16.
3. Alberti, K., Zimmet, P., Shaw, J., IDF Epidemiology Task Force Consensus Group. (2005) The metabolic syndrome-a new worldwide definition. Lancet, 366, 1059-62.
4. Alessi, M.C. and Juhan-Vague, I. (2006) PAI-1 and the metabolic syndrome: links, causes, and consequences. Arteriosclerosis, Thrombosis, and Vascular Biology, 26 (10), 2200-7.
5. Anderson, P.J., Chan, J.C.N., Chan, Y.L. et al. (1997) Visceral fat and cardiovascular risk factors in Chinese NIDDM patients. Diabetes Care, 20, 1854-8.
6. Anderson, P.J., Critchley, J.A.J.H., Chan, J.C.N. et al. (2001) Factor analysis of the metabolic syndrome: obesity versus insulin resistance as the central abnormality. International Journal of Obesity, 25, 1782-8.
7. Arkan, M.C., Hevener, A.L., Greten, F.R. et al. (2005) IKK-beta links inflammation to obesity-induced insulin resistance. Nature Medicine, 11 (2), 191-8.
8. Austin, M.A., Edwards, K.L., McNeely, M.J. et al. (2004) Heritability of multivariate factors of the metabolic syndrome in nondiabetic Japanese Americans. Diabetes, 53, 1166-9.
9. Axelrod, J. and Reisine, T.D. (1984) Stress hormones: their interaction and regulation. Science, 224, 452-9.
10. Baier, L.I., Sacchettini, J.C., Knowler, W.C. et al. (1995) An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. The Journal of Clinical Investigation, 95, 1281-7.
11. Balkau, B. and Charles, M.A. (1999) Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabetic Medicine: A Journal of the British Diabetic Association, 16 (5), 442-3.
12. Banerji, M.A., Chaiken, R.L., Huey, H. et al. (1994) GAD antibody negative NIDDM in adult Black subjects with diabetic ketoacidosis and increased frequency of leukocyte antigen DR3 and DR4. Flatbush Diabetes. Diabetes, 43, 741-5.
13. Barker, D.J.P., Hales, C.N., Fall, C.D. et al. (1993) Type 2 (non-insulin-dependent) diabetes mellitus, hypertension, and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia, 36, 62-7.
14. Bastard, J.P., Jardel, C., Bruckert, E. et al. (2000) Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. The Journal of Clinical Endocrinology and Metabolism, 85 (9), 3338-42.
15. Beltowski, J. (2006) Role of leptin in blood pressure regulation and arterial hypertension. Journal of Hypertension, 24 (5), 789-801.
16. Berg, A.H., Combs, T.P., Du, X. et al. (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nature Medicine, 7 (8), 947-53.
17. Björntorp, P. (1991) Metabolic implications of body fat distribution. Diabetes Care, 14, 1132-43.
18. Blouin, K., Després, J.P., Couillard, C. et al. (2005) Contribution of age and declining and rogen levels to features of the metabolic syndrome in men. Metabolism: Clinical and Experimental, 54 (8), 1034-40.
19. Boden, G. (2002) Interaction between free fatty acids and glucose metabolism. Current Opinion in Clinical Nutrition & Metabolic Care, 5 (5), 545-9.
20. Boden, G. and Shulman, G.I. (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. European Journal of Clinical Investigation, 32 (Suppl 3), 14-23.
21. Boden, G., Cheung, P., Stein, T.P. et al. (2002) FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis. American Journal of Physiology. Endocrinology and Metabolism, 283 (1), E12-9.
22. Bollheimer, L.C., Skelly, R.H., Chester, M.W. et al. (1998) Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. The Journal of Clinical Investigation, 101 (5), 1094-101.
23. Boyko, E.J., Fujimoto, W.Y., Leonetti, D.L. and Newell-Morris, L. (2000) Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care, 23, 465-71.
24. Butler, A.E., Janson, J., Bonner-Weir, S. et al. (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes, 52 (1), 102-10.
25. Cai, D., Yuan, M., Frantz, D.F. et al. (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nature Medicine, 11 (2), 183-90.
26. Carey, V.J., Walters, E.E., Colditz, G.A. et al. (1997) Body fat distribution and risk of non-insulin dependent diabetes mellitus in women. The Nurses' Health Study. American Journal of Epidemiology, 145, 614-9.
27. Carnethon, M.R., Gidding, S.S., Nehgme, R. et al. (2003) Cardiorespiratory fitness in young adulthood and the development of cardiovascular disease risk factors. Journal of American Medical Association, 290, 3092-100.
28. Caro, J.F., Kolaczynski, J.W., Nyce, M.R. et al. (1996) Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet, 348 (9021), 159-61.
29. Chan, D.C., Barrett, P.H. and Watts, G.F. (2006) Recent studies of lipoprotein kinetics in the metabolic syndrome and related disorders. Current Opinion in Lipidology, 17, 28-36.
30. Chan, J.C.N., Cheung, J.C.K., Lau, E.M.C. et al. (1996) The metabolic syndrome in Hong Kong Chinese-the inter-relationships amongst its components analysed by structural equation modelling. Diabetes Care, 19, 953-9.
31. Chan, J.C.N., Tong, P.C.Y. and Critchley, J.A.J.H. (2002) The insulin resistance syndrome-mechanism of clustering of cardiovascular risk. Seminars in Vascular Medicine, 2, 45-57.
32. Chan, J.M., Rimm, E.B., Colditz, G.A. et al. (1994) Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care, 17 (9), 961-9.
33. Chang, C.J., Wu, C.H., Yao, W.J. et al. (2000) Relationships of age, menopause and central obesity on cardiovascular disease risk factors in Chinese women. International Journal of Obesity and Related Metabolic Disorders, 24 (12), 1699-704.
34. Cheal, K.L., Abbasi, F., Lamendola, C. et al. (2004) Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes, 53 (5), 1195-200.
35. Chen, J., Gu, D., Chen, C.S. et al. (2007) Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrology, Dialysis, Transplantation. 22, 1100-6.
36. Chen, J., Muntner, P., Hamm, L. et al. (2004) The metabolic syndrome and chronic kidney disease in U.S. adults. Annals of Internal Medicine, 140, 167-74.
37. Chen, L., Hwang, S., Tsai, S. et al. (2000) Glucose intolerance in Chinese patients with chronic hepatitis C. World Journal of Gastroenterology, 9, 505-8.
38. Cheng, A.Y.S., Kong, A.P.S., Wong, V.W.S. et al. (2006) Chronic hepatitis B viral infection independently predicts renal outcome in type 2 diabetic patients. Diabetologia, 49, 1777-84.
39. Cheung, N. and Byth, K. (2003) Population health significance of gestational diabetes. Diabetes Care, 26, 2005-9.
40. Cho, Y.M., Park, K.S. and Lee, H.K. (2007) Genetic factors related to mitochondrial function and risk of diabetes mellitus. Diabetes Research and Clinical Practice, 77 (1), S172-7.
41. Colditz, G.A., Willett, W.C., Rotnitzky, A. and Manson, J.E. (1995) Weight gain as a risk factor for clinical diabetes mellitus in women. Annals of Internal Medicine, 122 (7), 481-6.
42. Colditz, G.A., Willett, W.C., Stampfer, M.J. et al. (1990) Weight as a risk factor for clinical diabetes in women. American Journal of Epidemiology, 132 (3), 501-13.
43. Colombo, C., Cutson, J.J., Yamauchi, T. et al. (2002) Transplantation of adipose tissue lacking leptin is unable to reverse the metabolic abnormalities associated with lipoatrophy. Diabetes, 51 (9), 2727-33.
44. Connolly, V., Unwin, N., Sherriff, P. et al. (2000) Diabetes prevalence and socioeconomic status: a population based study showing increased prevalence of type 2 diabetes mellitus in deprived areas. Journal of Epidemiology and Community Health, 54, 173-7.
45. Corrao, M.A., Guindon, G.E., Cokkinides, V. and Sharma, N. (2000) Building the evidence base for global tobacco control. Bulletin of the World Health Organization, 78 (7), 884-90.
46. Couillard, C., Ruel, G., Archer, W.R. et al. (2005) Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. Journal of Clinical Endocrinology and Metabolism, 90, 6454-9.
47. DeFronzo, R.A. (1992) Pathogenesis of type 2 (noninsulin dependent) diabetes mellitus: a balanced overview. Diabetologia, 35, 389-97.
48. DeFronzo, R.A. and Ferrannini, E. (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 14, 173-94.
49. DeFronzo, R.A., Simonson, D. and Ferrannini, E. (1982) Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 23 (4), 313-19.
50. Dekker, J.M., Girman, C., Rhodes, T. et al. (2005) Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation, 112 (5), 666-73.
51. Després, J.P. and Lemieux, I. (2006) Abdominal obesity and metabolic syndrome. Nature, 444 (7121), 881-7.
52. Deurenberg, P., Deurenberg-Yap, M. and Guricci, S. (2002) Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obesity Reviews, 3, 141-6.
53. Dresner, A., Laurent, D., Marcucci, M. et al. (1999) Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. The Journal of Clinical Investigation, 103 (2), 253-9.
54. Dunaif, A. (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews, 18 (6), 774-800.
55. Engeli, S., Schling, P., Gorzelniak, K. et al. (2003) The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?. The International Journal of Biochemistry & Cell Biology, 35 (6), 807-25.
56. Everhart, J.E., Pettitt, D.J., Bennett, P.H. and Knowler, W.C. (1992) Duration of obesity increases the incidence of NIDDM. Diabetes, 41 (2), 235-40.
57. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) (2001) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Journal of the American Medical Association, 285 (19), 2486-97.
58. Ferrannini, E., Barrett, E.J., Bevilacqua, S. and DeFronzo, R.A. (1983) Effect of fatty acids on glucose production and utilization in man. The Journal of Clinical Investigation, 72 (5), 1737-47.
59. Ford, E.S. (2005) Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care, 28, 1769-78.
60. Frayling, T.M. (2007) Nature Reviews. Genetics, 8 (9), 657-62.
61. Fraze, E., Donner, C.C., Swislocki, A.L. et al. (1985) Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. The Journal of Clinical Endocrinology and Metabolism, 61 (5), 807-11.
62. Frühbeck, G. (2006) Intracellular signalling pathways activated by leptin. The Biochemical Journal. 393 (Pt 1), 7-20.
63. Fuku, N., Park, K.S., Yamada, Y. et al. (2007) Mitochondrial haplogroup N9a confers resistance against type 2 diabetes in Asians. American Journal of Human Genetics, 80, 407-15.
64. Gavrilova, O., Marcus-Samuels, B., Graham, D. et al. (2000) Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. The Journal of Clinical Investigation, 105 (3), 271-8.
65. Glintborg, D., Stoving, R.K., Hagen, C. et al. (2005) Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism, 90 (10), 5605-12.
66. Go, A., Chertow, G., Fan, D. et al. (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New England Journal of Medicine, 351, 1296-305.
67. Golay, A., Zech, L., Shi, M.Z., et al. (1987) High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL. Journal of Clinical Endocrinology and Metabolism, 65 (3), 512-8.
68. Goodpaster, B.H., Thaete, F.L., Simoneau, J.A. and Kelley, D.E. (1997) Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes, 46 (10), 1579-85.
69. Grant, S.F. et al. (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nature Genetics, 48, 320-3.
70. Griffin, M.E., Marcucci, M.J., Cline, G.W. et al. (1999) Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signalling cascade. Diabetes, 48 (6), 1270-4.
71. Grundy, S.M. (2007) Metabolic syndrome: a multiplex cardiovascular risk factor. Journal of Clinical Endocrinology and Metabolism, 92, 399-404.
72. Guthrie, J.R., Taffe, J.R., Lehert, P. et al. (2004) Association between hormonal changes at menopause and the risk of a coronary event: a longitudinal study. Menopause, 11 (3), 315-22.
73. Haffner, S.M., Stern, M.P., Hazuda, H.P. et al. (1986) Upper body and centralized adiposity in Mexican Americans and non-Hispanic whites: relationship to body mass index and other behavioral and demographic variables. International Journal of Obesity, 10 (6), 493-502.
74. Hales, C.N. and Barker, D.J.P. (1992) Type 2 (non-insulin dependent) diabetes mellitus: The thrifty phenotype hypothesis. Diabetologia, 35, 595-601.
75. Hamman, R.F., Wing, R.R., Edelstein, S.L. et al. (2006) Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care, 29 (9), 2102-7.
76. Hancox, R., Milne, B. and Poulton, R. (2004) Association between child and adolescent television viewing and adult health: a longitudinal birth cohort study. Lancet, 364, 257-62.
77. Hansen, L., Hansen, T., Vestergaard, H. et al. (1995) A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatase-1 is associated with insulin resistance and hypersecretion of insulin. Human Molecular Genetics, 4, 1313-20.
78. Hattersley, A. and Pearson, E. (2006) Mini review: Pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology and genetics in diabetes. Endocrinology 147 (6), 2657-63.
79. Hayden, M.R., Tyagi, S.C., Kerklo, M.M. and Nicolls, M.R. (2005) Type 2 diabetes mellitus as a conformational disease. Journal of Pancreas, 6, 287-302.
80. He, M., Tan, K.C., Li, E.T. and Kung, A.W. (2001) Body fat determination by dual energy X-ray absorptiometry and its relation to body mass index and waist circumference in Hong Kong Chinese. International Journal of Obesity and Related Metabolic Disorder, 25, 748-52.
81. Higa, M., Zhou, Y.T., Ravazzola, M. et al. (1999) Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats. Proceedings of the National Academy of Sciences USA, 96 (20), 11513-8.
82. Hirosumi, J., Tuncman, G., Chang, L. et al. (2002) A central role for JNK in obesity and insulin resistance. Nature, 420 (6913), 333-6.
83. Holte, J. (1998) Polycystic ovary syndrome and insulin resistance: thrifty genes struggling with over-feeding and sedentary life style?. Journal of Endocrinological Investigation, 21 (9), 589-601.
84. Hong, Y., Pedersen, N., Brismar, K. and de Faire, U. (1997) Genetic and environmental architecture of the features of the insulin resistance syndrome. American Journal of Human Genetics, 60, 143-52.
85. Hotamisligil, G.S. (2005) Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes. Diabetes, 54 (Suppl 2), S73-8.
86. Hotamisligil, G.S., Arner, P., Caro, J.F. et al. (1995) Increased adipose tissue expression of tumour necrosis factor-a in human obesity and insulin resistance. The Journal of Clinical Investigation, 95, 2409-15.
87. Hotamisligil, G.S., Budavari, A., Murray, D. and Spiegelman, B.M. (1994) Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. The Journal of Clinical Investigation, 94, 1543-9.
88. Hotamisligil, G.S., Peraldi, P., Budavari, A. et al. (1996) IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-a and obesity-induced insulin resistance. Science, 271, 665-8.
89. Hotamisligil, G.S., Shargill, N.S. and Spiegelman, B.M. (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science, 259, 87-91.
90. Hu, F.B., Willett, W.C., Li, T. et al. (2004) Adiposity as compared with physical activity in predicting mortality among women. The New England Journal of Medicine, 351 (26), 2694-703.
91. Hubert, H., Snider, J. and Winkleby, M. (2005) Health status, health behaviors, and acculturation factors associated with overweight and obesity in Latinos from a community and agricultural labor camp survey. Preventive Medicine, 40, 642-51.
92. Hull, R.L., Andrikopoulos, S., Verchere, C.B. et al. (2003) Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid. Diabetes, 52 (2), 372-9.
93. Hull, R.L., Shen, Z.P., Watts, M.R. et al. (2005) Longterm treatment with rosiglitazone and metformin reduces the extent of, but does not prevent, islet amyloid deposition in mice expressing the gene for human islet amyloid polypeptide. Diabetes, 54 (7), 2235-44.
94. Hull, R.L., Westermark, G.T., Westermark, P. and Kahn, S.E. (2004) Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 89, 3629-43.
95. International Diabetes Federation. (2006) Unite for diabetes 2006, www.unitefordiabetes.org, last accessed 22 July 2008.
96. Inzucchi, S. and Sherwin, R. (2005) The prevention of type 2 diabetes mellitus. Endocrinology and Metabolism Clinics of North America, 34, 199-219.
97. Isomaa, B., Almgren, P., Tuomi, T. et al. (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 24, 683-9.
98. Itani, S.I., Ruderman, N.B., Schmieder, F. and Boden, G. (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes, 51 (7), 2005-11.
99. Jia, W.P., Lu, J.X., Kiang, K.S. et al. (2003) Prediction of abdominal visceral obesity from body mass index, waist circumference and waist-hip ratio in Chinese adults: receiver operating characteristics curves analysis. Biomedical Environmental Science, 2003, 206-11.
100. Jiang, Z.Y., Lin, Y.W., Clemont, A. et al. (1999) Characterization of selective resistance to insulin signalling in the vasculature of obese Zucker (fa/fa) rats. The Journal of Clinical Investigation, 104 (4), 447-57.
101. Johannsson, G., Marin, P., Lonn, L. et al. (1997) Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism and reduces diastolic blood pressure. Journal of Clinical Endocrinology and Metabolism, 82, 727-34.
102. Kaaja, R.J. and Poyhonen-Alho, M.K. (2006) Insulin resistance and sympathetic overactivity in women. Journal of Hypertension, 24, 131-41.
103. Kahn, S. (2001) The importance of β-cell failure in the development and progression of type 2 diabetes. The Journal of Clinical Endocrinology and Metabolism, 86, 4047-58.
104. Kahn, S.E. (2004) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia, 46, 3-19.
105. Kahn, R., Buse, J., Ferrannini, E., Stern, M., American Diabetes Association, European Association for the Study of Diabetes (2006) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 28, 2289-304.
106. Kanda, H., Tateya, S., Tamori, Y. et al. (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. The Journal of Clinical Investigation, 116 (6), 1494-1505.
107. Karter, A., Ferrara, A., Liu, J. et al. (2002) Ethnic disparities in diabetic complications in an insured population. Journal of American Medical Association, 287, 2519-27.
108. Kashyap, S., Belfort, R., Gastaldelli, A. et al. (2003) A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes, 52 (10), 2461-74.
109. Kaufman, J.M. and Vermeulen, A. (2005) The decline of and rogen levels in elderly men and its clinical and therapeutic implications. Endocrine Reviews, 26 (6), 833-76.
110. Kaufman, R.J., Scheuner, D., Schroder, M. et al. (2002) The unfolded protein response in nutrient sensing and differentiation. Nature Reviews. Molecular Cell Biology, 3 (6), 411-21.
111. Kern, P.A., Ranganathan, S., Li, C. et al. (2001) Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. American Journal of Physiology. Endocrinology and Metabolism, 280 (5), E745-51.
112. Kershaw, E.E. and Flier, J.S. (2004) Adipose tissue as an endocrine organ. The Journal of Clinical Endocrinology and Metabolism, 89 (6), 2548-56.
113. Knowler, W.C., Pettitt, D.J., Saad, M.F. et al. (1991) Obesity in the Pima Indians: its magnitude and relationship with diabetes. The American Journal of Clinical Nutrition, 53 (6 Suppl), 1543S-51S.
114. Ko, G.T.C., Chan, J.C.N. and Cockram, C.S. (2001) A low socioeconomic class is associated with diabetes and metabolic syndrome in Hong Kong Chinese. European Journal of Epidemiology, 17, 289-95.
115. Ko, G.T.C., Chan, J.C.N., Tsang, L.W. et al. (2000) Smoking and diabetes in Chinese men. Postgraduate Medical Journal, 77, 240-3.
116. Ko, G.T.C., Li, J.K.Y., Cheung, A.Y.K. et al. (1999) Two-hour post-glucose loading plasma glucose is the main determinant for the progression from impaired glucose tolerance to diabetes in Hong Kong Chinese. Diabetes Care, 22, 2096-7.
117. Krssak, M., Petersen, K.F., Dresner, A. et al. (1999) Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia, 42, 113-6.
118. Kubaszek, A., Pihlajamaki, J., Komarovski, V. et al. (2003) Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes, 52 (7), 1872-6.
119. Kulkarni, R.N., Bruning, J.C., Winnay, J.N. et al. (1999) Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell, 96 (3), 329-39.
120. Kylin, E. (1923) Studien über das Hypertonie-Hyperglykämie-Hyperurikämie. Zentralblatt für Innere Medizin, 44, 105-27.
121. Laaksonen, D.E., Niskanen, L., Punnonen, K. et al. (2004) Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27, 1036-41.
122. Lane, N. (2006) Mitochondrial disease: powerhouse of disease. Nature, 440, 600-2.
123. Lao, T.T., Tse, K.Y., Chan, L.Y. et al. (2003) HBsAg carrier status and the association between gestational diabetes with increased serum ferritin concentration in Chinese women. Diabetes Care, 26, 3011-6.
124. Lee, H.K., Park, K.S., Cho, Y.M. et al. (2005) Mitochon-dria-based model for fetal origin of adult disease and insulin resistance. Annals of the New York Academy of Sciences, 1042, 1-18.
125. Lee, M.K., Miles, P.D., Khoursheed, M. et al. (1994) Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes, 43 (12), 1435-9.
126. Lee, S.C., Hashim, Y., Li, J.K.Y. et al. (2001) The islet amyloid polypeptide (amylin) gene S20G mutation in Chinese subjects: Evidence for associations with type 2 diabetes and cholesterol levels. Journal of Endocrinology, 54, 541-6.
127. Lee, Z.S., Critchley, J.A., Ko, G.T. et al. (2002) Obesity and cardiovascular risk factors in Hong Kong Chinese. Obesity Reviews, 3 (3), 173-82.
128. Lee, Z.S.K., Critchley, J.A.J.H., Tomlinson, B. et al. (2001) Urinary epinephrine and norepinephrine with obesity, insulin and the metabolic syndrome in Hong Kong Chinese. Metabolism: Clinical and Experimental, 50, 135-43.
129. Lee, Y., Hirose, H., Ohneda, M. et al. (1994) Betacell lipotoxicity in the pathogenesis of noninsulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proceedings of the National Academy of Sciences USA, 91 (23), 10878-82.
130. Lehman, D.M. et al. (2007) Diabetes, 56, 389-93.
131. Leiter, L.A. (2005) Beta-cell preservation: a potential role for thiazolidinediones to improve clinical care in type 2 diabetes. Diabetic Medicine: A Journal of the Bπ'tish Diabetic Association, 22 (8), 963-72.
132. Li, J.K.Y., Ng, M.C.Y., So, W.Y. et al. (2006) Phenotypic and genetic clustering of diabetes and metabolic syndrome in Chinese families with type 2 diabetes mellitus. Diabetes/Metabolism Research and Reviews, 22, 46-52.
133. Li, T.Y., Rana, J.S., Manson, J.E. et al. (2006) Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation, 113 (4), 499-506.
134. Lillioja, S., Mott, D.M., Sprane, M. et al. (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. New England Journal of Medicine, 329, 1988-92.
135. Liou, C.W., Lin, T.K., Huei, W.H. et al. (2007) A common mitochondrial DNA variant and increased body mass index as associated factors for development of type 2 diabetes: Additive effects of genetic and environmental factors. Journal of Clinical Endocrinology and Metabolism, 92, 235-9.
136. Liu, K., Chan, Y., Chan, W. et al. (2003) Sonographic measurement of mesenteric fat thickness and its association with cardiovascular risk factors: comparison with subcutaneous and preperitoneal fat thickness, magnetic resonance imaging and anthropometric indexes. International Journal of Obesity, 27, 1267-73.
137. Liu, K., Chan, Y., Chan, W. et al. (2006) Mesenteric fat thickness is an independent determinant of metabolic syndrome and defines subjects with increased carotid intima-media thickness. Diabetes Care, 29, 379-84.
138. Liu, K., Chan, Y.L., Chan, J.C. et al. (2006) Mesenteric fat thickness as an independent determinant of fatty liver. International Journal of Obesity, 30 (5), 787-93.
139. Liu, Z., Zhang, Y.W., Chang, Y.S. and Fang, F.D. (2006) The role of cytoskeleton in glucose regulation. Biochemistry 71(5), 476-80.
140. Lo, M.K.W., Lee, K.F., Chan, N. et al. (2004) Effects of gender, Helicobacter pylori (HP) and hepatitis B virus serology status on cardiovascular and renal complications in Chinese type 2 diabetic patients with overt nephropathy. Diabetes, Obesity and Metabolism, 6, 223-30.
141. Lyssenko V., Lupi R., Marchetti P. et al. (2007) Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. The Journal of Clinical Investigation, 117, 2155-63.
142. Magnusson, I., Rothman, D.L., Katz, L.D. et al. (1992) Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. The Journal of Clinical Investigation, 90 (4), 1323-7.
143. Malik, S., Wong, N.D., Franklin, S.S. et al. (2004) Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 110, 1245-50.
144. Martin, M.L. and Jensen, M.D. (1991) Effects of body fat distribution on regional lipolysis in obesity. The Journal of Clinical Investigation, 88, 609-13.
145. Mathis, D., Vence, L. and Benoist, C. (2001) β-cell death during progression to diabetes. Nature, 414, 792-8.
146. McCarthy, M. and Zeggini, E. (2006) Genetics of type 2 diabetes. Current Report in Diabetes, 6, 147-54.
147. McNeely, M.J., Boyko, E.J., Shofer, J.B. et al. (2001) Standard definitions of overweight and central adiposity for determining diabetes risk in Japanese Americans. The American Journal of Clinical Nutrition, 74 (1), 101-7.
148. Medina, J., Fernandez-Salazar, L.I., Garcia-Buey, L. and Moreno-Otero, R. (2004) Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diabetes Care, 27 (8), 2057-66.
149. Mehta, S.H., Brancati, F.L., Sulkowski, M.S. et al. (2000) Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Annals of Internal Medicine, 133 (8), 592-9.
150. Meigs, J.B., D'Agostino, R.B.S., Wilson, P.W. et al. (1997) Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes, 46, 1594-1600.
151. Meigs, J., Williams, K., Sullivan, L. et al. (2004) Using metabolic syndrome traits for efficient detection of impaired glucose tolerance. Diabetes Care, 27, 1417-26.
152. Mi, J., Law, C., Zhang, K.L. et al. (2000) Effects of infant birth weight and maternal body mass index in pregnancy on components of the insulin resistance syndrome in China. Annals of Internal Medicine, 132, 253-60.
153. Minokoshi, Y., Kim, Y.B., Peroni, O.D. et al. (2002) Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature, 415 (6869), 339-43.
154. Mitrakou, A., Kelly, D., Mokan, M. et al. (1992) Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. The New England Journal of Medicine, 326, 22-9.
155. Mohamed-Ali, V., Goodrick, S., Rawesh, A. et al. (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. The Journal of Clinical Endocrinology and Metabolism, 82 (12), 4196-200.
156. Moitra, J., Mason, M.M., Olive, M. et al. (1998) Life without white fat: a transgenic mouse. Genes and Development, 12 (20), 3168-81.
157. Molarius, A., Seidell, J.C., Sans, S. et al. (1999) Varying sensitivity of waist action levels to identify subjects with overweight or obesity in 19 populations of the WHO MONICA Project. Journal of Clinical Epidemiology, 52 (12), 1213-24.
158. Molarius, A., Seidell, J.C., Sans, S. et al. (1999) Waist and hip circumferences, and waist-hip ratio in 19 populations of the WHO MONICA Project. International Journal of Obesity and Related Metabolic Disorders, 23 (2), 116-25.
159. Morino, K., Petersen, K.F., Dufour, S. et al. (2005) Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. The Journal of Clinical Investigation, 115 (12), 3587-93.
160. Morino, K., Petersen, K.F. and Shulman, G.I. (2006) Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes, 55 (Suppl 2), S9-15.
161. Morrish, N.J., Wang, S., Stevens, L.K. et al. (2001) Mortality and causes of death in the WHO Multinational Survey of Vascular Diseases in Diabetes. Diabetologia, 44 (Suppl 2), S14-21.
162. Muller, M., Grobbee, D.E., den Tonkelaar, I. et al. (2005) Endogenous sex hormones and metabolic syndrome in aging men. The Journal of Clinical Endocrinology and Metabolism, 90 (5), 2618-23.
163. Nakatani, Y., Kaneto, H., Kawamori, D. et al. (2005) Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. The Journal of Biological Chemistry, 280 (1), 847-51.
164. Ng, M.C. et al. (2007) Replication and identification of novel variants at TCF7L2 associated with type 2 diabetes in Hong Kong Chinese. The Journal of Clinical Endocrinology and Metabolism, 92 (9), 3733-7.
165. Ng, M.C., So, W.Y., Cox, N.J. et al. (2004) Genome wide scan for metabolic syndrome and related quantitative traits in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21-25. Diabetes, 53, 2676-83.
166. Ng, M.C.Y., Lee, S.C., Ko, G.T.C. et al. (2001) Familial early onset type 2 diabetes in Chinese: the more significant roles of obesity and genetics than autoimmunity. Diabetes Care, 24, 667-71.
167. Ng, M.C.Y., So, W.Y., Cox, N.J. et al. (2004) Genome wide scan for type 2 diabetes loci in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21-q25. Diabetes, 53, 1609-13.
168. Ng, M.C.Y., Yeung, V.T.F., Chow, C.C. et al. (2000) Mitochondrial DNA A3243G mutation in patients with early or late onset type 2 diabetes mellitus in Hong Kong Chinese. Journal of Endocrinology, 52, 557-64.
169. Niswender, K.D. and Schwartz, M.W. (2003) Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signalling capabilities. Frontiers in Neuroendocrinology, 24 (1), 1-10.
170. O'Rahilly, S., Turner, R. and Matthews, D. (1988) Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. New England Journal of Medicine, 318, 1225-30.
171. Oh, J.Y., Hong, Y.S., Sung, Y.A. and Barrett-Connor, E. (2004) Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care, 27, 2027-32.
172. Ohneda, M., Inman, L.R. and Unger, R.H. (1995) Caloric restriction in obese pre-diabetic rats prevents betacell depletion, loss of beta-cell GLUT 2 and glucose incompetence. Diabetologia, 38, 173-9.
173. Ozcan, U., Cao, Q., Yilmaz, E. et al. (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science, 306 (5695), 457-61.
174. Pan, X.R., Yang, W.Y., Li, G.W. and Liu, J. (1997) Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care, 20, 1664-9.
175. Park, Y.W., Zhu, S., Palaniappan, L. et al. (2003) The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Archives of Internal Medicine, 163 (4), 427-36.
176. Patti, M.E., Butte, A.J., Crunkhorn, S. et al. (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proceedings of the National Academy of Sciences USA, 100 (14), 8466-71.
177. Pecoits-Filho, R., Lindholm, B. and Stenvinkel, P. (2002) The malnutrition, inflammation, and atherosclerosis (MIA) syndrome-the heart of the matter. Nephrology, Dialysis, Transplantation, 17 (Suppl 11), 28-31.
178. Pereira, M., Kartashov, A., Ebbeling, C. et al. (2005) Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis. Lancet, 365, 36-42.
179. Petersen, K.F., Befroy, D., Dufour, S. et al. (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science, 300 (5622), 1140-2.
180. Petersen, K.F., Dufour, S., Befroy, D. et al. (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. New England Journal of Medicine, 350, 664-71.
181. Pickup, J. (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care, 27 813-23.
182. Pitteloud, N., Mootha, V.K., Dwyer, A.A. et al. (2005) Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care, 28 (7), 1636-42.
183. Poitou, V. and Robertson, R. (2002) Minireview: secondary beta-cell failure in type 2 diabetes-a convergence of glucotoxicity and lipotoxicity. Endocrinology, 143, 339-42.
184. Pradhan, A.D., Manson, J.E., Rifai, N. et al. (2001) C-reactive protein, interleukin 6 and risk of developing type 2 diabetes mellitus. Journal of American Medical Association, 286, 327-34.
185. Rana, J.S., Li, T.Y., Manson, J.E. and Hu, F.B. (2007) Adiposity compared with physical inactivity and risk of type 2 diabetes in women. Diabetes Care, 30 (1), 53-8.
186. Randle, P.J., Hales, C.N., Garland, P.B. and Newsholme, E.A. (1963) The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet, ii, 785-9.
187. Rask-Madsen, C. and King, G.L. (2007) Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes. Nature Clinical Practice Endocrinology & Metabolism, 3 (1), 46-56.
188. Ratziu, V., Trabut, J.B. and Poynard, T. (2004) Fat, diabetes, and liver injury in chronic hepatitis C. Current Gastroenterology Reports, 6 (1), 22-9.
189. Reaven, G.M. (1988) Role of insulin resistance in human disease. Banting lecture 1988. Diabetes, 37, 1595-607.
190. Reaven, G.M. (2006) The metabolic syndrome: is this diagnosis necessary? American Journal of Clinical Nutrition, 83, 1237-47.
191. Reitman, M.L., Arioglu, E., Gavrilova, O. and Taylor, S.I. (2000) Lipoatrophy revisited. Trends in Endocrinology and Metabolism, 11 (10), 410-6.
192. Richelsen, B., Pedersen, S.B., Moller-Pedersen, T. and Bak, J.F. (1991) Regional differences in triglyceride breakdown in human adipose tissue: effects of catecholamines, insulin, and prostaglandin E2. Metabolism: Clinical and Experimental, 40 (9), 990-6.
193. Roglic, G., Unwin, N., Bennett, P. et al. (2005) The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care, 28, 2130-5.
194. Saad, M.F., Lillioja, S., Nyomba, B.L. et al. (1991) Racial differences in the relation between blood pressure and insulin resistance. New England Journal of Medicine, 324, 733-9.
195. Sarafidis, P.A. and Ruilope, L.M. (2006) Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. American Journal of Nephrology, 26 (3), 232-44.
196. Sarnak, M., Levey, A.S., Schoolwerth, A. et al. (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension, 42, 1050-65.
197. Sawada, S., Lee, I., Muto, T. et al. (2003) Cardiorespiratory fitness and the incidence of type 2 diabetes: prospective study of Japanese men. Diabetes Care, 26, 2918-22.
198. Schmitz-Peiffer, C., Browne, C.L., Oakes, N.D. et al. (1997) Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes, 46 (2), 169-78.
199. Shai, I., Jiang, R., Manson, J.E. et al. (2006) Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care, 29, 1585-90.
200. Shimabukuro, M., Ohneda, M., Lee, Y. and Unger, R.H. (1997) Role of nitric oxide in obesity-induced beta cell disease. The Journal of Clinical Investigation, 100, 290-5.
201. Shoelson, S.E., Lee, J. and Yuan, M. (2003) Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity-and diet-induced insulin resistance. International Journal of Obesity and Related Metabolic Disorders, 27 (Suppl 3), S49-52.
202. Shulman, G.I., Rothman, D.L., Jue, T. et al. (1990) Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. The New England Journal of Medicine, 322 (4), 223-8.
203. So, W.Y., Kong, A.P.S., Osaki, R. et al. (2006) Hong Kong Diabetes Registry 2: Glomerular filtration rate, cardiovascular endpoints and all-cause mortality in type 2 diabetic patients. Diabetes Care, 29, 2046-52.
204. Soma, J., Saito, T., Taguma, Y. et al. (2000) High prevalence and adverse effect of hepatitis C virus infection in type II diabetic-related nephropathy. Journal of the American Society of Nephrology, 11 (4), 690-9.
205. Steinthorsdottir, V. et al. (2007) Nature Genetics, 39 (6), 770-5, 459.
206. Sundstrom, J., Riserus, U., Byberg, L. et al. (2006) Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. British Medical Journal, 332, 878-82.
207. Suzuki, S., Oka, Y., Kadowaki, T. et al. (2003) Clinical features of diabetes mellitus with the mitochondrial DNA 3243 (A-G) mutation in Japanese: maternal inheritance and mitochondria-related complications. Diabetes Research and Clinical Practice, 59 (3), 207-17.
208. Swerdloff, R.S. and Wang, C. (1993) Androgens and aging in men. Experimental Gerontology, 28 (4-5), 435-46.
209. Swislocki, A.L., Chen, Y.D., Golay, A. et al. (1987) Insulin suppression of plasma-free fatty acid concentration in normal individuals and patients with type 2 (noninsulin-dependent) diabetes. Diabetologia, 30 (8), 622-6.
210. Syvänne, M. and Taskinen, M.R. (1997) Lipids and lipoproteins as coronary risk factors in noninsulin-dependent diabetes mellitus. Lancet, 350 (Suppl 1), S120-3.
211. Tan, C.E., Ma, S., Wai, D. et al. (2004) Can we apply the National Cholesterol Education Program Adult Treatment Panel Definition of the Metabolic Syndrome to Asians?. Diabetes Care, 27 (5), 1182-6.
212. Tan, K.C.B., Mackay, I.R., Zimmet, P.Z. et al. (2000) Metabolic and immunologic features of Chinese patients with atypical diabetes mellitus. Diabetes Care, 23, 338-53.
213. Tan, K.C., Wat, N.M., Tam, S.C. et al. (2003) C-reactive protein predicts the deterioration of glycemia in Chinese subjects with impaired glucose tolerance. Diabetes Care, 26, 2323-8.
214. Tanaka, S., Horimai, C. and Katsukawa, F. (2003) Ethnic differences in abdominal visceral fat accumulation between Japanese, African-Americans, and Caucasians: a meta-analysis. Acta Diabetologia, 40, S302-4.
215. Tanaka, H., Shiohira, Y., Uezu, Y. et al. (2006) Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney International, 69, 369-74.
216. Taskinen, M.R. (1992) Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes, 41 (Suppl 2), 12-7.
217. The DECODA Study Group (2006) Prevalence of the metabolic syndrome in populations of Asian origin. Comparison of the IDF definition with the NCEP definition. Diabetes Research and Clinical Practice, 76, 57-67.
218. Tomlinson, J.W. and Stewart, P.M. (2005) Mechanisms of disease: Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome. Nature Clinical Practice Endocrinology & Metabolism, 1 (2), 92-9.
219. Tong, P.C.Y., Ho, C.S., Yeung, V.T.F. et al. (2005) Low testosterone and insulin-like growth factor-I but high C-reactive protein are independent predictors for metabolic syndrome in Chinese middle-aged men with a family history of type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 90, 6418-23.
220. Trujillo, M.E., Sullivan, S., Harten, I. et al. (2004) Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro. The Journal of Clinical Endocrinology and Metabolism, 89 (11), 5577-82.
221. Tuomilehto, J., Lindstrom, J., Eriksson, J.G. et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine, 344, 1343-50.
222. Unger, R.H. (2003) Mini review: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology, 144 (12), 5159-65.
223. Unwin, N., Harland, J., White, M. et al. (1997) Body mass index, waist circumference, waist-hip ratio and glucose intolerance in Chinese and Europid adults in Newcastle, UK. Journal of Epidemiology and Community Health, 51, 160-6.
224. Van Gaal, L.F., Mertens, I.L. and De Block, C.E. (2006) Mechanisms linking obesity with cardiovascular disease. Nature, 444 (7121), 875-80.
225. Van Haeften, T., Pimento, W., Mitrakou, A. et al. (2000) Relative contributions of β-cell function and tissue insulin sensitivity to fasting and post-glucose-load glycemia. Metabolism: Clinical and Experimental, 49, 1318-25.
226. Vaxillaire, M. and Froguel, P. (2008) Monogenic Diabetes of the Young, Pharacogenetics and relevance to multifactorial forms of type 2 diabetes. Endocrine Reviews, 29(3), 254-64.
227. Vgontzas, A.N., Papanicolaou, D.A., Bixler, E.O. et al. (2000) Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. The Journal of Clinical Endocrinology and Metabolism, 85 (3), 1151-8.
228. Vozarova, B., Weyer, C., Hanson, K. et al. (2001) Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obesity Research, 9 (7), 414-7.
229. Wallenius, K., Wallenius, V., Sunter, D. et al. (2002a) Intracerebroventricular interleukin-6 treatment decreases body fat in rats. Biochemical and Biophysical Research Communications, 293 (1), 560-5.
230. Wallenius, V., Wallenius, K., Ahren, B. et al. (2002b) Interleukin-6-deficient mice develop mature-onset obesity. Nature Medicine, 8 (1), 75-9.
231. Wang, J., Qiao, Q., Miettinen, M. et al. (2004) The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a Chinese population with high postprandial glucose. Diabetes Care, 27, 2429-37.
232. Wang, Y., Rimm, E.B., Stampfer, M.J. et al. (2005) Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. American Journal of Clinical Nutrition, 81, 555-63.
233. Wannamethee, S.G. and Shaper, A.G. (1999) Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care, 22 (8), 1266-72.
234. Wat, N.M., Lam, T.H., Janus, E.D. and Lam, K.S. (2001) Central obesity predicts the worsening of glycaemia in southern Chinese. International Journal of Obesity and Related Metabolic Disorder, 25, 1789-93.
235. Wei, J., Sung, F., Li, C. et al. (2003) Low birth weight and high birth weight infants are both at an increased risk to have type 2 diabetes among schoolchildren in Taiwan. Diabetes Care, 26, 343-8.
236. Weinstein, A.R., Sesso, H.D., Lee, I.M. et al. (2004) Relationship of physical activity vs body mass index with type 2 diabetes in women. Journal of American Medical Association, 292 (10), 1188-94.
237. Weisberg, S.P., McCann, D., Desai, M. et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. The Journal of Clinical Investigation, 112 (12), 1796-808.
238. Weyer, C., Bogardus, C., Mott, D.M. and Pratley, R.E. (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. The Journal of Clinical Investigation, 104 (6), 787-94.
239. Weyer, C., Funahashi, T., Tanaka, S. et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. The Journal of Clinical Endocrinology and Metabolism, 86 (5), 1930-5.
240. WHO expert consultation. (2004) Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. Lancet, 363, 157-63.
241. Widen, E., Lehto, M., Kanninen, T. et al. (1995) Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. New England Journal of Medicine, 333, 348-51.
242. Wofford, M.R. and Hall, J.E. (2004) Pathophysiology and treatment of obesity hypertension. Current Pharmaceutical Design, 10 (29), 3621-37.
243. World Health Organization (1999) Department of Noncommunicable Disease Surveillance. Definition, diagnosis and classification of diabetes mel-litus and its complications.
244. World Health Organization (2005) Preventing chronic diseases-a vital investment. http://www.who.int/chp/chronic_disease_report/en/index.html, (last accessed 1 June 2006).
245. Wu, A.Y., Kong, N.C., de Leon, F.A. et al. (2005) An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the Micro Albuminuria Prevalence (MAP) Study. Diabetologia, 48, 1674-5.
246. Xia, Z., Sniderman, A.D. and Cianflone, K. (2002) Acylation-stimulating protein (ASP) deficiency induces obesity resistance and increased energy expenditure in ob/ob mice. The Journal of Biological Chemistry, 277 (48), 45874-9.
247. Xiang, K., Wang, Y., Zheng, T. et al. (2004) Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24. Diabetes, 53, 228-34.
248. Xu, J.Y., Dan, Q.H., Chan, V. et al. (2005) Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients. European Journal of Human Genetics, 13, 422-7.
249. Yajnik, C.S. (2002) The lifecycle effects of nutrition and body size on adult adiposity, diabetes and cardiovascular diseases. Obesity Reviews, 3, 217-24.
250. Yajnik, C. and Yudkin, J. (2004) The Y-Y paradox. Lancet, 363, 163.
251. Yamauchi, T., Kamon, J., Minokoshi, Y. et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine, 8 (11), 1288-95.
252. Yamauchi, T., Kamon, J., Waki, H. et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine, 7 (8), 941-6.
253. Yamauchi, T., Kamon, J., Waki, H. et al. (2003) Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. The Journal of Biological Chemistry, 278 (4), 2461-8.
254. Yokoi, N., Kanamori, M., Horikawa, Y. et al. (2006) Association studies of variants in the genes involved in pancreatic beta-cell function in type 2 diabetes in Japanese subjects. Diabetes, 55 (8), 2379-86.
255. Zeggini, E. and McCarthy, M.I. 2007. Diabetologia, 50, 1-4.
256. Zhao, H.L., Lai, F.M.M., Tong, P.C.Y. et al. (2003) Prevalence and clinicopathological characteristics of islet amyloid in Chinese patients with type 2 diabetes. Diabetes, 52, 2759-66.
257. Zhou, Y.P. and Grill, V. (1995) Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans. The Journal of Clinical Endocrinology and Metabolism, 80 (5), 1584-90.
258. Zhu, S., Heymsfield, S.B., Toyoshima, H. et al. (2005) Race-ethnicity-specific waist circumference cutoffs for identifying cardiovascular disease risk factors. The American Journal of Clinical Nutrition, 81 (2), 409-15.
259. Zhu, S., Wang, Z., Heshka, S. et al. (2002) Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. The American Journal of Clinical Nutrition, 76 (4), 743-9.
260. Zimmet, P., Alberti, K.G. and Shaw, J. (2001) Global and societal implications of the diabetes epidemic. Nature, 414, 782-7.